Search Within

Parastoo Bahrami Dahi

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (107)
  2. Journal Article (58)
  3. Research Letter (6)
  4. Correspondence (1)
Groups
  1. Bone Marrow Transplant (172)
  2. CTCR Scholars (172)
  3. Center for Hematologic Malignancies (172)
  4. Department of Medicine (172)
  5. Epidemiology and Biostatistics (172)
  6. Hematologic Malignancies, Division of (172)

More Groups

People
  1. Sean Devlin (155)
  2. Sergio Giralt (135)
  3. Miguel-Angel Perales (132)
  4. Gunjan Shah (110)
  5. Michael Scordo (92)
  6. Craig Sauter (83)

More People

Years
  1. 2025 (6)
  2. 2024 (13)
  3. 2023 (28)
  4. 2022 (15)
  5. 2021 (13)
  6. 2020 (29)

More Years

Publications
  1. Blood (50)
  2. Biology of Blood and Marrow Transplantation (41)
  3. Bone Marrow Transplantation (18)
  4. Transplantation and Cellular Therapy (15)
  5. Blood Advances (12)
  6. Leukemia and Lymphoma (5)

More Publications

Publishers
  1. American Society of Hematology (62)
  2. Elsevier Inc. (62)
  3. Nature Publishing Group (23)
  4. Taylor & Francis Group (5)
  5. American Society of Clinical Oncology (4)
  6. American Society for Clinical Investigation (3)

More Publishers

Results (172)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Stem cell mobilization and autograft minimal residual disease negativity with novel induction regimens in multiple myeloma
    Journal Article

    Bal, S.; Landau, H. J.; Shah, G. L.; Scordo, M.; Dahi, P.; Lahoud, O. B.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lendvai, N.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma
    Journal Article

    Wudhikarn, K.; Palomba, M. L.; Pennisi, M.; Garcia-Recio, M.; Flynn, J. R.; Devlin, S. M.; Afuye, A.; Silverberg, M. L.; Maloy, M. A.; Shah, G. L.; more...
    Blood Cancer Journal (2020)

    Fulltext@MSK | Save
  • DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality
    Journal Article

    Wudhikarn, K.; Pennisi, M.; Garcia-Recio, M.; Flynn, J. R.; Afuye, A.; Silverberg, M. L.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. L.; Shah, G. L.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Baseline immune status predicts response to adoptive therapy with CMV cytotoxic T-Cells for refractory CMV
    Meeting Abstract

    Fabrizio, V.; Rodriguez-Sanchez, I.; Mauguen, A.; Dahi, P. B.; O'Reilly, R. J.; Prockop, S. E.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Burden and impact of toxicities on outcomes for aggressive B cell non-Hodgkin lymphoma patients after CD19-directed chimeric antigen receptor T cell: Real-world experience
    Meeting Abstract

    Wudhikarn, K.; Pennisi, M.; Garcia Recio, M.; Flynn, J.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. W.; Shah, G. L.; Scordo, M.; Palomba, M. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparison of conditioning regimens for allogeneic hematopoietic cell transplantation in non-Hodgkin lymphoma
    Meeting Abstract

    Peterson, K. T.; Lin, A.; Ruiz, J. D.; Zheng, J.; Devlin, S. M.; Shah, G. L.; Scordo, M.; Sauter, C. S.; Perales, M.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Successful personalization of propylene glycol free melphalan (PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT) using pharmacokinetic (PK)-directed dosing
    Meeting Abstract

    Shah, G. L.; Lin, A.; Kamrowski, A.; Carino, C. A.; Schofield, R.; Devlin, S. M.; Bhatt, V.; Proli, A. J.; Chung, D. J.; Dahi, P. B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Don't let the HCT-CI fool you: Similar outcomes with myeloablative CD34+ selected allo-HCT compared to unmodified RIC allo-HCT in patients with AML or MDS and high comorbidity scores
    Meeting Abstract

    Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; Politikos, I.; Sanchez-Escamilla, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Long-term survival in patients with AML or MDS relapsed after allogeneic hematopoietic cell transplantation: Importance of second cell therapy
    Meeting Abstract

    Zuanelli Brambilla, C.; Ruiz, J. D.; Lobaugh, S. M.; Dahi, P. B.; Young, J. W.; Gyurkocza, B.; Shaffer, B. C.; Ponce, D. M.; Tamari, R.; Sanchez Escamilla, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparing car T cells toxicities grading systems: Application of ASTCT grading system and implications for management
    Meeting Abstract

    Pennisi, M.; Jain, T.; Mead, E.; Santomasso, B.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Devlin, S. M.; Batlevi, C. W.; Brentjens, R.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save